title: [Low doses of cytarabine in the treatment of acute non-lymphoblastic leukemia in adults].
abstract: Low doses of cytarabine were used in the therapy of 33 adult patients with non-lymphoblastic leukemia. A total of 37.5% of complete remissions were recorded in the group of primary patients, and 36% of complete remissions--in the group of resistant patients and in those with relapses. Indications have been determined, and an opinion on the mechanism of action of low doses of cytarabine has been expressed.
authors.forename: F E
authors.initials: FE
authors.lastname: Faĭnshteĭn
authors.forename: R A
authors.initials: RA
authors.lastname: Kucher
authors.forename: V G
authors.initials: VG
authors.lastname: Isaev
authors.forename: E M
authors.initials: EM
authors.lastname: Abakumov
authors.forename: G P
authors.initials: GP
authors.lastname: Shakhbaian
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D003561:Cytarabine
vernacular_title: Malye dozy tsitozara v lechenii ostrykh nelimfoblastnykh leĭkozov vzroslykh.